NSABP B-42: Does extending letrozole to 10 years make a difference?
At 15 years, extended letrozole reduced distant recurrences by 2.8%, with approximately 3 fewer metastatic recurrences per 100 women, without a significant OS benefit. Tailored treatment duration is the key.
At 15 years, extended letrozole reduced distant recurrences by 2.8%, with approximately 3 fewer metastatic recurrences per 100 women, without a significant OS benefit. Tailored treatment duration is the key.